New Key Statistics Module, Z-Score and F-Score
NAS:SYRE Key Ratios
| Market Cap $ M | 1,351.78 |
| Enterprise Value $ M | 1,197.43 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | -- |
| Price/Sales | 144.03 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | -- |
| EPS (TTM) $ | -72.84 |
| Beneish M-Score | -5 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | 21.80 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -9.31 |
| EV-to-EBITDA | -9.38 |
| PEG | -- |
| Shares Outstanding M | 40.28 |
| Net Margin (%) | -38,238.15 |
| Operating Margin % | -14,510.61 |
| Pre-tax Margin (%) | -38,241.08 |
| Quick Ratio | 10.68 |
| Current Ratio | 10.68 |
| ROA % (ttm) | -184.88 |
| ROE % (ttm) | -- |
| ROIC % (ttm) | -269.44 |
| Dividend Yield % | -- |
| Altman Z-Score | -0.17 |
SYRE Number of Guru Trades
SYRE Volume of Guru Trades
Gurus Latest Trades with NAS:SYRE
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:SYRE is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Spyre Therapeutics Inc Insider Transactions
No Available Data
News about NAS:SYRE
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers